| Search & browse in old database A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
glucagon-like-immunoreactivity (MeSH) - C0061361 L0061361 S0161471 A0188835 M0064369 MeSH NM C015236 → |
Read definition... |
|
glucagon-NAPS (MeSH) - C0061362 L0126463 S0161472 A0188836 M0088481 MeSH CE C027147 → |
Read definition... |
|
Glucagon-Secreting Cell - C0030280 L2546862 S6358516 A8412170 M0011742 MeSH PM D050416 → |
Read definition... |
|
Glucagon-Secreting Cells - C0030280 L2546862 S6358515 A8412169 M0011742 MeSH MH D050416 → |
Read definition... |
|
Glucagonoma - C0017689 L0017689 S0045095 A0063696 M0009315 MeSH MH D005935 → |
Read definition... |
|
Glucagonomas - C0017689 L0017689 S0045096 A0063699 M0009315 MeSH PM D005935 → |
Read definition... |
|
glucal-6-phosphate (MeSH) - C0294386 L0363288 S0523531 A0597964 M0243132 MeSH NM C092084 → |
Read definition... |
|
glucametacin (MeSH) - C0061377 L0126466 S0161475 A0188839 M0056167 MeSH CE C010581 → |
Read definition... |
|
glucametacine (MeSH) - C0061377 L0126466 S0161476 A0188840 M0056167 MeSH CE C010581 → |
Read definition... |
|
glucamethacin1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid monohydrate glucosamide (MeSH) - C0061377 L0126468 S0161477 A0188841 M0056167 MeSH CE C010581 → |
Read definition... |
